{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:08:10Z","timestamp":1747224490337,"version":"3.40.5"},"reference-count":9,"publisher":"PAGEPress Publications","issue":"3","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatismo"],"abstract":"<jats:p>Since the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) pandemic outbreak, vaccines gained a growing role. Possible vaccine-related side effects range from minor local events to more prominent systemic manifestations up to anaphylactic reactions. A heterogeneous spectrum of cutaneous reactions has been reported, ranging from local injection site reactions to urticarial and morbilliform eruptions, pernio\/chilblains and zoster flares. Here, we describe a case of varicella zoster virus reactivation following mRNA coronavirus 2019 vaccine and discuss the available literature upon the topic published so far.<\/jats:p>","DOI":"10.4081\/reumatismo.2021.1445","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T08:19:27Z","timestamp":1637655567000},"source":"Crossref","is-referenced-by-count":9,"title":["Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis"],"prefix":"10.4081","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-3520","authenticated-orcid":false,"given":"B.","family":"Maranini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ciancio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cultrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"605","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020; 383(27). [Epub ahead of print]."},{"key":"606","doi-asserted-by":"crossref","unstructured":"Cohen JI. Clinical practice: Herpes zoster. N Engl J Med. 2013; 369: 255-63.","DOI":"10.1056\/NEJMcp1302674"},{"key":"607","doi-asserted-by":"crossref","unstructured":"Walter R, Hartmann K, Fleisch F, et al. Reactivation of herpesvirus infections after vaccinations? Lancet (London, England). 1999; 353: 810.","DOI":"10.1016\/S0140-6736(99)00623-6"},{"key":"608","doi-asserted-by":"crossref","unstructured":"Bostan E, Yalici-Armagan B. Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence? J Cosmet Dermatol. 2021; 20: 1566-7.","DOI":"10.1111\/jocd.14035"},{"key":"609","doi-asserted-by":"crossref","unstructured":"Eid E, Abdullah L, Kurban M, Abbas O. Herpes zoster emergence following mRNA COVID-19 vaccine. J Med Virol. 2021; 93: 5231-2.","DOI":"10.1002\/jmv.27036"},{"key":"610","doi-asserted-by":"crossref","unstructured":"McMahon DE, Amerson A, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021; 85: 46-55.","DOI":"10.1016\/j.jaad.2021.03.092"},{"key":"611","doi-asserted-by":"crossref","unstructured":"Furer V, Zisman D, Kibari A, et al. Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology (Oxford, England). 2021. [Epub ahead of print].","DOI":"10.1093\/rheumatology\/keab702"},{"key":"612","doi-asserted-by":"crossref","unstructured":"Zhang C, Maruggi G, Shan H, Li J. Advances in mRNA vaccines for infectious diseases. Front Immunol. 2019; 10: 594.","DOI":"10.3389\/fimmu.2019.00594"},{"key":"613","doi-asserted-by":"crossref","unstructured":"Furer V, Rondaan C, Heijstek M, et al. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open. 2019; 5: e001041.","DOI":"10.1136\/rmdopen-2019-001041"}],"container-title":["Reumatismo"],"original-title":[],"link":[{"URL":"https:\/\/reumatismo.org\/index.php\/reuma\/article\/download\/1445\/921","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reumatismo.org\/index.php\/reuma\/article\/download\/1445\/921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T13:21:55Z","timestamp":1637760115000},"score":1,"resource":{"primary":{"URL":"https:\/\/reumatismo.org\/index.php\/reuma\/article\/view\/1445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":9,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,11,22]]}},"URL":"https:\/\/doi.org\/10.4081\/reumatismo.2021.1445","relation":{},"ISSN":["2240-2683","0048-7449"],"issn-type":[{"type":"electronic","value":"2240-2683"},{"type":"print","value":"0048-7449"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}